SCHEMBL13779484

SCHEMBL13779484

CCc1csc(-n2ccnc2)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.36
CYP1A2 P05177 2/20 0.36
CYP2D6 P10635 2/20 0.36
CYP2C19 P33261 2/20 0.36
CYP19A1 P11511 2/20 0.36
CYP2C9 P11712 1/20 0.36
OGA O60502 1/20 0.35
CHEK1 O14757 1/20 0.34
LOXL2 Q9Y4K0 1/20 0.33
TDP1 Q9NUW8 2/20 0.33
HRH4 Q9H3N8 1/20 0.33
ALOX15 P16050 1/20 0.33
HSD17B10 Q99714 1/20 0.33
CYP11B1 P15538 2/20 0.33
CYP11B2 P19099 2/20 0.33
LMNA P02545 2/20 0.33
TSHR P16473 1/20 0.33
MEN1 O00255 1/20 0.33
USP2 O75604 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6560596 0.83 CHEK1 (0.37) CYP3A4CYP1A2CYP19A1OGACHEK1
SCHEMBL9925916 0.77 L3MBTL1 (0.39) CYP3A4CYP1A2CYP2D6CYP2C19CYP19A1
SCHEMBL18855235 0.75 CYP3A4 (0.33) CYP3A4CYP1A2CYP2D6CYP2C19CYP19A1
SCHEMBL19309238 0.75 LMNA (0.33) CYP3A4CYP1A2CYP2D6CYP2C19CYP19A1
SCHEMBL18708314 0.74 CHEK1 (0.39) CYP3A4CYP1A2CYP2D6CYP2C19CYP19A1
SCHEMBL18708315 0.74 LMNA (0.43) CYP3A4CYP1A2CYP2D6CYP2C19CYP19A1
SCHEMBL12402348 0.74 CYP3A4 (0.37) CYP3A4CYP1A2CYP19A1CHEK1TDP1
SCHEMBL179306 0.73 OGA (0.36) CYP3A4CYP1A2CYP2D6CYP2C19CYP19A1
SCHEMBL15306650 0.73 LMNA (0.46) CYP3A4CYP1A2CYP2D6CYP2C19CYP19A1
SCHEMBL11919182 0.71 HRH4 (0.39) CYP3A4CYP1A2CYP2D6CYP2C19CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9822131-B2 Certain chemical entities, compositions and methods INTELLIKINE LLC (US) 2017-11-21 US disclosed
US-9682141-B2 Combination of kinase inhibitors and uses thereof INTELLIKINE LLC (US) 2017-06-20 US disclosed
US-9655892-B2 Certain chemical entities, compositions and methods INTELLIKINE LLC (US) 2017-05-23 US disclosed
WO-2015168079-A1 PYRIMIDINE OR PYRIDINE DERIVATIVES USEFUL AS PI3K INHIBITORS INFINITY PHARMACEUTICALS, INC. (US) 2015-11-05 WO disclosed
WO-2014151147-A1 COMBINATION OF KINASE INHIBITORS AND USES THEREOF INTELLIKINE, LLC (US) 2014-09-25 WO disclosed
WO-2013078441-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF INTELLIKINE, LLC (US) 2013-05-30 WO disclosed
WO-2013071264-A1 COMBINATION OF KINASE INHIBITORS AND USES THEREOF INTELLIKINE, LLC (US) 2013-05-16 WO disclosed
WO-2013012918-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF INFINITY PHARMACEUTICALS INC. (US) 2013-01-24 WO disclosed
WO-2009088986-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS INTELLIKINE, INC. (US) 2009-07-16 WO disclosed